{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:33:35Z","timestamp":1784691215573,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00259-019-04396-3","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T05:59:27Z","timestamp":1562219967000},"page":"2065-2076","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson\u2019s disease patients with impulse control disorders"],"prefix":"10.1007","volume":"46","author":[{"given":"I.","family":"Navalpotro-Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dacosta-Aguayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Molinet-Dronda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Martin-Bastida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Botas-Pe\u00f1in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Jimenez-Urbieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Delgado-Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Quiroga-Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6863-5481","authenticated-orcid":false,"given":"Maria C.","family":"Rodriguez-Oroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"4396_CR1","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1523\/JNEUROSCI.20-06-02369.2000","volume":"20","author":"SN Haber","year":"2000","unstructured":"Haber SN, Fudge JL, McFarland NR. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci. 2000;20:2369\u201382.","journal-title":"J Neurosci"},{"key":"4396_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neuroscience.2014.10.008","volume":"282","author":"SN Haber","year":"2014","unstructured":"Haber SN. The place of dopamine in the cortico-basal ganglia circuit. Neuroscience. 2014;282:248\u201357.","journal-title":"Neuroscience."},{"key":"4396_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ana.410380407","volume":"38","author":"JP Seibyl","year":"1995","unstructured":"Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, et al. Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson\u2019s disease. Ann Neurol. 1995;38:589\u201398.","journal-title":"Ann Neurol"},{"key":"4396_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.parkreldis.2015.02.015","volume":"21","author":"G Santangelo","year":"2015","unstructured":"Santangelo G, Vitale C, Picillo M, Cuoco S, Moccia M, Pezzella D, et al. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson\u2019s disease patients. Parkinsonism Relat Disord. 2015;21:489\u201393.","journal-title":"Parkinsonism Relat Disord"},{"key":"4396_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11910-017-0788-0","volume":"17","author":"S Thobois","year":"2017","unstructured":"Thobois S, Prange S, Sgambato-Faure V, Tremblay L, Broussolle E. Imaging the etiology of apathy, anxiety, and depression in Parkinson\u2019s disease: implication for treatment. Curr Neurol Neurosci Rep. 2017;17:76.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4396_CR6","doi-asserted-by":"publisher","unstructured":"Son HJ, Jeong YJ, Yoon HJ, Kim JW, Choi GE, Park JH, et al.Parkinson disease-related cortical and striatal cognitive patterns in dual time F-18 FP CIT: evidence for neural correlates between the caudate and the frontal lobe. Q J Nucl Med Mol Imaging. 2017. \n                    https:\/\/doi.org\/10.23736\/S1824-4785.17.02976-4\n                    \n                  .","DOI":"10.23736\/S1824-4785.17.02976-4"},{"key":"4396_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67:589\u201395.","journal-title":"Arch Neurol"},{"key":"4396_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00702-012-0933-5","volume":"120","author":"NJ Ray","year":"2013","unstructured":"Ray NJ, Strafella AP. Imaging impulse control disorders in Parkinson\u2019s disease and their relationship to addiction. J Neural Transm (Vienna). 2013;120:659\u201364.","journal-title":"J Neural Transm (Vienna)"},{"key":"4396_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbd.2010.03.013","volume":"39","author":"R Cilia","year":"2010","unstructured":"Cilia R, Ko JH, Cho SS, van Eimeren T, Marotta G, Pellecchia G, et al. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson\u2019s disease and pathological gambling. Neurobiol Dis. 2010;39:98\u2013104.","journal-title":"Neurobiol Dis"},{"key":"4396_CR10","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/mds.24941","volume":"27","author":"J Joutsa","year":"2012","unstructured":"Joutsa J, Martikainen K, Niemel\u00e4 S, Johansson J, Forsback S, Rinne JO, et al. Increased medial orbitofrontal [18F]fluorodopa uptake in parkinsonian impulse control disorders. Mov Disord. 2012;27:778\u201382.","journal-title":"Mov Disord"},{"key":"4396_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mds.25886","volume":"29","author":"C Vriend","year":"2014","unstructured":"Vriend C, Nordbeck AH, Booij J, van der Werf YD, Pattij T, Voorn P, et al. Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease: reduced DaT BR predates ICD in PD. Mov Disord. 2014;29:904\u201311.","journal-title":"Mov Disord"},{"key":"4396_CR12","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/archneur.65.12.1604","volume":"65","author":"R Cilia","year":"2008","unstructured":"Cilia R, Siri C, Marotta G, Isaias IU, De Gaspari D, Canesi M, et al. Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol. 2008;65:1604\u201311.","journal-title":"Arch Neurol"},{"key":"4396_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181fc27fa","volume":"75","author":"T van Eimeren","year":"2010","unstructured":"van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TDL, Houle S, et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology. 2010;75:1711\u20136.","journal-title":"Neurology"},{"key":"4396_CR14","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/brain\/awr080","volume":"134","author":"V Voon","year":"2011","unstructured":"Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandez H, et al. Dopamine agonists and risk: impulse control disorders in Parkinson\u2019s; disease. Brain. 2011;134:1438\u201346.","journal-title":"Brain"},{"key":"4396_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.parkreldis.2010.12.014","volume":"17","author":"A Djamshidian","year":"2011","unstructured":"Djamshidian A, O\u2019Sullivan SS, Lees A, Averbeck BB. Stroop test performance in impulsive and non impulsive patients with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2011;17:212\u20134.","journal-title":"Parkinsonism Relat Disord"},{"key":"4396_CR16","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","volume":"24","author":"D Weintraub","year":"2009","unstructured":"Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease. Mov Disord. 2009;24:1461\u20137.","journal-title":"Mov Disord"},{"key":"4396_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Mamikonyan E, Papay K, Shea JA, Xie SX, Siderowf A. Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease-rating scale. Mov Disord. 2012;27:242\u20137.","journal-title":"Mov Disord"},{"key":"4396_CR18","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord. 2007;22:1689\u2013707 quiz 1837.","journal-title":"Mov Disord"},{"key":"4396_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society task force guidelines. Mov Disord. 2012;27:349\u201356.","journal-title":"Mov Disord"},{"key":"4396_CR20","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord. 2010;25:2649\u201353.","journal-title":"Mov Disord"},{"key":"4396_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0010-0277(94)90018-3","volume":"50","author":"A Bechara","year":"1994","unstructured":"Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7\u201315.","journal-title":"Cognition"},{"key":"4396_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1088\/0031-9155\/47\/1\/301","volume":"47","author":"C Comtat","year":"2002","unstructured":"Comtat C, Kinahan PE, Fessler JA, Beyer T, Townsend DW, Defrise M, et al. Clinically feasible reconstruction of 3D whole-body PET\/CT data using blurred anatomical labels. Phys Med Biol. 2002;47:1\u201320.","journal-title":"Phys Med Biol"},{"key":"4396_CR23","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00259-011-1745-9","volume":"38","author":"BA Thomas","year":"2011","unstructured":"Thomas BA, Erlandsson K, Modat M, Thurfjell L, Vandenberghe R, Ourselin S, et al. The importance of appropriate partial volume correction for PET quantification in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2011;38:1104\u201319.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4396_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","volume":"54","author":"AC Tziortzi","year":"2011","unstructured":"Tziortzi AC, Searle GE, Tzimopoulou S, Salinas C, Beaver JD, Jenkinson M, et al. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. NeuroImage. 2011;54:264\u201377.","journal-title":"NeuroImage."},{"key":"4396_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2009.129","volume":"35","author":"SN Haber","year":"2010","unstructured":"Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010;35:4\u201326.","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 2","key":"4396_CR26","doi-asserted-by":"publisher","first-page":"S721","DOI":"10.1002\/mds.22590","volume":"24","author":"C Scherfler","year":"2009","unstructured":"Scherfler C, Nocker M. Dopamine transporter SPECT: how to remove subjectivity? Mov Disord. 2009;24(Suppl 2):S721\u20134.","journal-title":"Mov Disord"},{"key":"4396_CR27","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1093\/brain\/awh485","volume":"128","author":"C Scherfler","year":"2005","unstructured":"Scherfler C, Seppi K, Donnemiller E, Goebel G, Brenneis C, Virgolini I, et al. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson\u2019s disease. Brain J Neurol. 2005;128:1605\u201312.","journal-title":"Brain J Neurol"},{"key":"4396_CR28","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00259-012-2198-5","volume":"39","author":"D Garcia-Garcia","year":"2012","unstructured":"Garcia-Garcia D, Clavero P, Gasca Salas C, Lamet I, Arbizu J, Gonzalez-Redondo R, et al. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2012;39:1767\u201377.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4396_CR29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2967\/jnumed.111.089946","volume":"52","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, et al. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J Nucl Med. 2011;52:848\u201355.","journal-title":"J Nucl Med"},{"key":"4396_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/00004728-199507000-00006","volume":"19","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Foster NL, Kuhl DE. Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr. 1995;19:541\u20137.","journal-title":"J Comput Assist Tomogr"},{"key":"4396_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8","volume":"10","author":"JL Lancaster","year":"2000","unstructured":"Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp. 2000;10:120\u201331.","journal-title":"Hum Brain Mapp"},{"issue":"Suppl 7","key":"4396_CR32","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1002\/mds.10579","volume":"18","author":"W Pirker","year":"2003","unstructured":"Pirker W. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Mov Disord. 2003;18(Suppl 7):S43\u201351.","journal-title":"Mov Disord"},{"key":"4396_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00259-012-2276-8","volume":"40","author":"A Varrone","year":"2013","unstructured":"Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, et al. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging. 2013;40:213\u201327.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4396_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jnnp-2013-305395","volume":"85","author":"V Voon","year":"2014","unstructured":"Voon V, Rizos A, Chakravartty R, Mulholland N, Robinson S, Howell NA, et al. Impulse control disorders in Parkinson\u2019s disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry. 2014;85:148\u201352.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4396_CR35","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","volume":"87","author":"KM Smith","year":"2016","unstructured":"Smith KM, Xie SX, Weintraub D. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry. 2016;87:864\u201370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4396_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.parkreldis.2016.05.028","volume":"30","author":"E Premi","year":"2016","unstructured":"Premi E, Pilotto A, Garibotto V, Bigni B, Turrone R, Alberici A, et al. Impulse control disorder in PD: a lateralized monoaminergic frontostriatal disconnection syndrome? Parkinsonism Relat Disord. 2016;30:62\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"4396_CR37","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/ejn.12644","volume":"40","author":"BJ Everitt","year":"2014","unstructured":"Everitt BJ. Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories - indications for novel treatments of addiction. Eur J Neurosci. 2014;40:2163\u201382.","journal-title":"Eur J Neurosci"},{"key":"4396_CR38","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/brain\/awx105","volume":"140","author":"J Reber","year":"2017","unstructured":"Reber J, Feinstein JS, O\u2019Doherty JP, Liljeholm M, Adolphs R, Tranel D. Selective impairment of goal-directed decision-making following lesions to the human ventromedial prefrontal cortex. Brain. 2017;140:1743\u201356.","journal-title":"Brain."},{"issue":"8","key":"4396_CR39","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1002\/hbm.24068","volume":"39","author":"A Verger","year":"2018","unstructured":"Verger A, Klesse E, Chawki MB, Witjas T, Azulay JP, Eusebio A, et al. Brain PET substrate of impulse control disorders in Parkinson\u2019s disease: a metabolic connectivity study. Hum Brain Mapp. 2018;39(8):3178\u201386. \n                    https:\/\/doi.org\/10.1002\/hbm.24068\n                    \n                  .","journal-title":"Hum Brain Mapp"},{"key":"4396_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neubiorev.2012.11.003","volume":"37","author":"M Criaud","year":"2013","unstructured":"Criaud M, Boulinguez P. Have we been asking the right questions when assessing response inhibition in go\/no-go tasks with fMRI? A meta-analysis and critical review. Neurosci Biobehav Rev. 2013;37:11\u201323.","journal-title":"Neurosci Biobehav Rev"},{"key":"4396_CR41","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/mds.23247","volume":"25","author":"A Djamshidian","year":"2010","unstructured":"Djamshidian A, Jha A, O\u2019Sullivan SS, Silveira-Moriyama L, Jacobson C, Brown P, et al. Risk and learning in impulsive and nonimpulsive patients with Parkinson\u2019s disease. Mov Disord. 2010;25:2203\u201310.","journal-title":"Mov Disord"},{"key":"4396_CR42","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00213-009-1697-y","volume":"207","author":"V Voon","year":"2010","unstructured":"Voon V, Reynolds B, Brezing C, Gallea C, Skaljic M, Ekanayake V, et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology. 2010;207:645\u201359.","journal-title":"Psychopharmacology"},{"key":"4396_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neubiorev.2017.02.018","volume":"77","author":"G Santangelo","year":"2017","unstructured":"Santangelo G, Raimo S, Barone P. The relationship between impulse control disorders and cognitive dysfunctions in Parkinson\u2019s disease: a meta-analysis. Neurosci Biobehav Rev. 2017;77:129\u201347.","journal-title":"Neurosci Biobehav Rev"},{"key":"4396_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1176\/appi.neuropsych.12030076","volume":"25","author":"J Mack","year":"2013","unstructured":"Mack J, Okai D, Brown RG, Askey-Jones S, Chaudhuri KR, Martin A, et al. The role of self-awareness and cognitive dysfunction in Parkinson\u2019s disease with and without impulse-control disorder. J Neuropsychiatr Clin Neurosci. 2013;25:141\u20139.","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"4396_CR45","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/mds.23567","volume":"26","author":"C Vitale","year":"2011","unstructured":"Vitale C, Santangelo G, Trojano L, Verde F, Rocco M, Grossi D, et al. Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson\u2019s disease. Mov Disord. 2011;26:830\u20136.","journal-title":"Mov Disord"},{"key":"4396_CR46","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s10072-012-1224-5","volume":"34","author":"AR Bentivoglio","year":"2013","unstructured":"Bentivoglio AR, Baldonero E, Ricciardi L, De Nigris F, Daniele A. Neuropsychological features of patients with Parkinson\u2019s disease and impulse control disorders. Neurol Sci. 2013;34:1207\u201313.","journal-title":"Neurol Sci"},{"key":"4396_CR47","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature11239","volume":"488","author":"SA Sheth","year":"2012","unstructured":"Sheth SA, Mian MK, Patel SR, Asaad WF, Williams ZM, Dougherty DD, et al. Human dorsal anterior cingulate cortex neurons mediate ongoing behavioural adaptation. Nature. 2012;488:218\u201321.","journal-title":"Nature"},{"key":"4396_CR48","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/brain\/awf199","volume":"125","author":"U Schroeder","year":"2002","unstructured":"Schroeder U, Kuehler A, Haslinger B, Erhard P, Fogel W, Tronnier VM, et al. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain J Neurol. 2002;125:1995\u20132004.","journal-title":"Brain J Neurol"},{"key":"4396_CR49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00702-016-1549-y","volume":"123","author":"F Pineau","year":"2016","unstructured":"Pineau F, Roze E, Lacomblez L, Bonnet A-M, Vidailhet M, Czernecki V, et al. Executive functioning and risk-taking behavior in Parkinson\u2019s disease patients with impulse control disorders. J Neural Transm (Vienna). 2016;123:573\u201381.","journal-title":"J Neural Transm (Vienna)"},{"key":"4396_CR50","doi-asserted-by":"publisher","unstructured":"Biars JW, Johnson NL, Nespeca M, Busch RM, Kubu CS, Floden DP. Iowa gambling task performance in Parkinson disease patients with impulse control disorders. Arch Clin Neuropsychol. 2019;34(3):310\u20138. \n                    https:\/\/doi.org\/10.1093\/arclin\/acy036\n                    \n                  .","DOI":"10.1093\/arclin\/acy036"},{"key":"4396_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1468-1331.2009.02792.x","volume":"17","author":"M Rossi","year":"2010","unstructured":"Rossi M, Gerschcovich ER, De Achaval D, Perez-Lloret S, Cerquetti D, Cammarota A, et al. Decision-making in Parkinson\u2019s disease patients with and without pathological gambling: decision-making in PD with pathological gambling. Eur J Neurol. 2010;17:97\u2013102.","journal-title":"Eur J Neurol"},{"key":"4396_CR52","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3389\/fneur.2018.00654","volume":"9","author":"A Martini","year":"2018","unstructured":"Martini A, Dal Lago D, Edelstyn NMJ, Grange JA, Tamburin S. Impulse control disorder in Parkinson\u2019s disease: a meta-analysis of cognitive, affective, and motivational correlates. Front Neurol. 2018;9:654.","journal-title":"Front Neurol"},{"key":"4396_CR53","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.parkreldis.2012.05.022","volume":"18","author":"R Erro","year":"2012","unstructured":"Erro R, Pappat\u00e0 S, Amboni M, Vicidomini C, Longo K, Santangelo G, et al. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson\u2019s disease patients. Parkinsonism Relat Disord. 2012;18:1034\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"4396_CR54","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.parkreldis.2017.02.010","volume":"37","author":"M Picillo","year":"2017","unstructured":"Picillo M, Santangelo G, Erro R, Cozzolino A, Amboni M, Vitale C, et al. Association between dopaminergic dysfunction and anxiety in de novo Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;37:106\u201310.","journal-title":"Parkinsonism Relat Disord"},{"key":"4396_CR55","first-page":"227","volume":"46","author":"D Weintraub","year":"2005","unstructured":"Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson\u2019s disease. J Nucl Med. 2005;46:227\u201332.","journal-title":"J Nucl Med"},{"key":"4396_CR56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2011.06.056","volume":"310","author":"TS Moriyama","year":"2011","unstructured":"Moriyama TS, Felicio AC, Chagas MHN, Tardelli VS, Ferraz HB, Tumas V, et al. Increased dopamine transporter density in Parkinson\u2019s disease patients with social anxiety disorder. J Neurol Sci. 2011;310:53\u20137.","journal-title":"J Neurol Sci"},{"key":"4396_CR57","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.parkreldis.2012.06.007","volume":"18","author":"AFG Leentjens","year":"2012","unstructured":"Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE. Anxiety and motor fluctuations in Parkinson\u2019s disease: a cross-sectional observational study. Parkinsonism Relat Disord. 2012;18:1084\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 2","key":"4396_CR58","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/brain\/119.2.585","volume":"119","author":"PK Morrish","year":"1996","unstructured":"Morrish PK, Sawle GV, Brooks DJ. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson\u2019s disease. Brain J Neurol. 1996;119(Pt 2):585\u201391.","journal-title":"Brain J Neurol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04396-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04396-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04396-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T23:08:55Z","timestamp":1593731335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04396-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["4396"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04396-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"20 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"I.N.-G. received honoraria for travel and accommodation to attend scientific meetings from Zambon. R.D.-A., F.M.-D., H.J.-U, B.G. and A.Q.-V. have no disclosures to declare. A.M.-B received honoraria for travel and accommodation from Zambon and Bial. M.C.R.-O. received honoraria for lectures, travel and accommodation to attend scientific meetings from Abbvie, Zambon, Bial and Boston Scientific, and she received financial support for her research from national and local government funding agencies in Spain (Institute of Health Carlos III, Basque Country Local Government, and CIBERNED). M.D.-A. received honoraria for travel and accommodation to attend scientific meetings from UCB and Zambon. None of these bodies influenced the content of the manuscript or the decision to publish in any way.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures carried out involving human participants were in accordance with the ethical standards of the Gipuzkoa Clinical Research Ethics Committee, and with the principles of the 1964 Declaration of Helsinki and its later amendments, or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the participants prior to their inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}